Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Recruiting · NCT04340024 · Observational (researchers observe without assigning treatment) · Lead sponsor: National Cancer Centre, Singapore
View the official record on ClinicalTrials.gov →What this trial is about
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
Who can take part
Age range
21 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with severe side effects from radiotherapy
- Patients with a type of cancer that is associated with sensitivity to radiotherapy
Exclusion criteria
- Age of patient must be between 21 (inclusive) and 99 (exclusive)
Where it is running
1 location listed.
- National Cancer Center Singapore - Singapore, Singapore